Targeted Temperature Management in Acute Neurologic EEmergency

TTM636154455708298264

Program Overview
This activity is targeted to the multidisciplinary team treating and caring for patients undergoing Targeted Temperature Management (TTM) for acute neurological illnesses in the critical care setting, specifically post cardiac arrest, traumatic brain injury, acute ischemic and hemorrhagic stroke, hepatic encephalopathy and fever control. It provides detailed practical approaches on the delivery of TTM: induction, maintenance, rewarming and maintenance of normothermia in different settings and acute neurological illnesses. Complications and anticipated side effects of cooling are discussed to maximize the benefit of cooling for approved indications.

Target Audience
This enduring program has been designed for practicing physicians, physicians in training, advanced practice and staff nurses, pharmacists, physician assistants, clinical nurse specialists, emergency care providers, including EMTs and paramedics; researchers, students, all professionals, providing care in the critical care setting.

Learning Objectives
Upon completion of the educational activity, participants should be able to:

  1. Examine the impact and benefit of temperature control in the Neuro population
  2. Compare the role of hypothermia in cardiac arrest, TBI, stroke and hepatic encephalopathy
  3. Define complications associated with TTM
  4. Explain how to implement a TTM program

CME/CE Credit
CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
Physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through thejoint providership of AKH Inc., Advancing Knowledge in Healthcare and the Neurocritical Care Society. AKH Inc. Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants: NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Nurses: AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is awarded 1.0 contact hour.Nurse Practitioners: AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803. This program is accredited for 1.0 contact hour(s) which includes 0 hour(s) of pharmacology. Program. ID #21442. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.

Criteria for Success
Statements of credit will be awarded based on the participant reviewing monograph in its entirety,scoring at least 70% on the self-assessment test, completing and submitting an activity evaluation. To complete the activity please visit: www.neurocriticalcare.org/ttm. There is no fee to participate in this activity. You must participate in the entire activity to receivecredit. If you have any questions about this CME/CE activity please contact AKH at tbrignoni@akhcme.com.

Commercial Support
This activity is supported by an educational grant from The Global Science Center for TTM underwritten by Bard Medical.